Related Experiment Videos
Veterinary pharmacovigilance in the European context
1CNITV (Centre National d'Informations Toxicologiques Vétérinaires), Ecole Nationale Vétérinaire de Lyon, France.
Annali Dell'Istituto Superiore Di Sanita
|January 1, 1992
Summary
Veterinary pharmacovigilance monitors adverse drug reactions (ADRs) in animals. Enhancing this system requires clear scope, established priorities, and improved collaboration between practitioners, universities, industry, and authorities.
Area of Science:
- Veterinary Medicine
- Pharmacology
- Drug Safety
Background:
- Veterinary pharmacovigilance involves monitoring adverse drug reactions (ADRs) in animals.
- Defining the scope of veterinary pharmacovigilance is crucial, considering factors like efficacy, resistance, human effects, and residues.
- Establishing priorities for adverse effects in animals is necessary for an effective system.
Purpose of the Study:
- To define the scope and priorities of veterinary pharmacovigilance.
- To explore methodological tools for ADR surveillance.
- To analyze the current state and future directions of veterinary pharmacovigilance systems.
Main Methods:
- Review of existing definitions and scope of veterinary pharmacovigilance.
- Discussion of methodological tools (causality assessment, data banks, alert systems).
- Analysis of different pharmacovigilance system models (administrative vs. interactive).
Main Results:
- Veterinary pharmacovigilance systems vary significantly between countries.
- Two main system types exist: administrative (authority-led) and interactive (university-linked).
- Industry involvement is growing, necessitating further collaboration.
Conclusions:
- Veterinary pharmacovigilance requires clear scope definition and prioritization.
- Development of methodological tools is ongoing.
- Enhanced cooperation among veterinarians, universities, industry, and regulatory bodies is essential for advancing veterinary drug safety.